Characterisation and application of recombinant FVIII‐neutralising antibodies from haemophilia A inhibitor patients-Reference-Cited by-同舟云学术

Characterisation and application of recombinant FVIII‐neutralising antibodies from haemophilia A inhibitor patients

Published:2021-05-10 Issue:5 Volume:193 Page:976-987
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Coxon Carmen H.¹^ORCID,Yu Xinren²,Beavis James³,Diaz‐Saez Laura⁴,Riches‐Duit Andrew¹,Ball Chris¹,Diamond Scott L.²,Raut Sanj¹

Affiliation:

1. National Institute for Biological Standards and Control Hertfordshire UK

2. University of Pennsylvania Philadelphia PA USA

3. Oxford Haemophilia Centre Churchill Hospital OxfordUK

4. Structural Genomics Consortium Oxford UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17227

Reference45 articles.

1. Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity

2. Concentrations of infliximab and anti-drug antibodies in relation to clinical response in patients with rheumatoid arthritis

3. Drug safety and immunogenicity of tumour necrosis factor inhibitors: the story so far

4. Thromboembolic events associated with bevacizumab plus chemotherapy for patients with colorectal cancer: a meta‐analysis of randomized controlled trials;Alahmari AK;Am Health Drug Benefits,2016

5. Inhibitory antibodies in hemophilia A

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain;Journal of Thrombosis and Haemostasis;2024-09

2. Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor;Blood Journal;2023-05-16

3. Mechano-covalent protection of coagulation factor VIII by von Willebrand factor;Blood Advances;2022-10-14

4. Expanding the Malaria Antibody Toolkit: Development and Characterisation of Plasmodium falciparum RH5, CyRPA, and CSP Recombinant Human Monoclonal Antibodies;Frontiers in Cellular and Infection Microbiology;2022-06-16

5. FVIII inhibitors display FV‐neutralizing activity in the prothrombin time assay;Journal of Thrombosis and Haemostasis;2021-05-20